Health literacy program for school-age children with cystic fibrosis and their parents
The Effect of Education Given to School-Age Children With Cystic Fibrosis and Their Parents on Health Literacy Levels
This program will test whether an online education course improves health literacy for children aged 6–11 who have cystic fibrosis and their parents.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 6 Years to 11 Years |
| Sex | All |
| Sponsor | University of Yalova Academic / other |
| Locations | 1 site (Yalova) |
| Trial ID | NCT07304362 on ClinicalTrials.gov |
What this trial studies
This randomized pretest–posttest controlled trial will enroll about 104 children aged 6–11 with cystic fibrosis and their parents and randomly assign them to an online education program or to usual care. Baseline and four-week posttest data will be collected using the Health Literacy Scale for School-Age Children and the Turkish Health Literacy Scale-32. The intervention group will receive an online education program developed by the researcher while the control group will receive no additional intervention. Outcomes will compare changes in parents' and children's ability to understand, evaluate, and use health information between groups.
Who should consider this trial
Good fit: Children aged 6–11 with cystic fibrosis who are followed at the participating CF clinic, speak Turkish, can complete questionnaires, and whose parents consent are ideal candidates.
Not a fit: Children with severe visual, auditory, or cognitive impairments, those outside the 6–11 age range, or those who have already received health literacy education are unlikely to benefit.
Why it matters
Potential benefit: If successful, the program could help children and parents better understand health information and manage daily cystic fibrosis care.
How similar studies have performed: Education programs for chronic pediatric conditions have shown mixed results, and targeted online health-literacy interventions specifically for school-age children with CF are relatively novel and not widely tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Children aged 6-11 years at the time of the study. Children receiving treatment at the Cystic Fibrosis Diagnosis and Treatment Center during the study period. Children able to understand and complete the Health Literacy Scales (no visual, auditory, or cognitive impairments that would prevent scale completion). Children with sufficient proficiency in Turkish to answer the scales. Children and parents who voluntarily agree to participate. Children who have not previously received any health literacy education. Exclusion Criteria: Children with severe visual, auditory, or cognitive impairments that would prevent them from understanding or completing the scales. Children who have already received health literacy education. Children who are outside the age range of 6-11 years. Children not receiving follow-up at the Cystic Fibrosis Diagnosis and Treatment Center during the study period.
Where this trial is running
Yalova
- Yalova Universty — Yalova, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: DUYGU DEMİR Associate Professor
- Email: duygu.demir@yalova.edu.tr
- Phone: +905053662358
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.